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Introduction {#sec1}
============

α-Thalassemia X-linked mental retardation (ATR-X) syndrome is a rare congenital X-linked disorder resulting in moderate to severe intellectual disability (ID), developmental delay, microcephaly, hypomyelination, and a mild form of α-thalassemia (OMIM: [301040](301040){#intref0010}) ([@bib24]). In a recent study of \~1,000 individuals with ID, *ATRX* mutations were identified as one of the most frequent causes of non-syndromic ID ([@bib28]), emphasizing a key requirement for this gene in cognitive processes. ATRX-related ID arises from hypomorphic mutations in the *ATRX* gene, most commonly in the highly conserved ATRX/DNMT3/DNMT3L and Switch/Sucrose non-fermenting domains ([@bib25], [@bib26]). The former targets ATRX to chromatin by means of a histone reader domain that recognizes specific histone tail modifications ([@bib17]), and the latter confers ATPase activity and is critical for its chromatin remodeling activity ([@bib46]; [@bib62]).

ATRX, in a complex with the histone chaperone death domain-associated protein (DAXX), promotes the deposition of the histone variant H3.3 at heterochromatic domains, including telomeres and pericentromeres ([@bib27]; [@bib43]). However, ATRX is also required for the deposition of H3.3 within the gene body of a subset of G-rich genes, to reduce G-quadruplex formation, and to promote transcriptional elongation ([@bib45]). ATRX is also required for the postnatal suppression of a network of imprinted genes in the neonatal brain by promoting long-range chromatin interactions via CCCTC-binding factor (CTCF) and cohesin ([@bib38]).

In mice, germline deletion of *Atrx* results in embryonic lethality ([@bib21]), while conditional deletion of *Atrx* in neuroprogenitors leads to excessive DNA damage caused by DNA replication stress and subsequent Tp53-dependent apoptosis ([@bib72]; [@bib93]). Mice with the deletion of exon 2 of *Atrx* (*Atrx* ^*ΔE2*^) were generated that result in the global reduction of *Atrx* expression. These mice are viable and exhibit impaired novel object recognition memory, spatial memory in the Barnes maze, and contextual fear memory ([@bib74]). Molecular defects identified in these mice included decreased activation of calcium/calmodulin-dependent protein kinase II (CaMKII) and the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor in the hippocampus, decreased spine density in the medial prefrontal cortex, and altered DNA methylation and increased expression of *Xlr3b* in neurons ([@bib75]). Our group also reported similar behavioral impairments in female mice that exhibit a mosaic expression of ATRX in the central nervous system ([@bib81]). However, the contribution of different cell types and sex differences to behavioral abnormalities has not yet been resolved.

To address these questions, we deleted *Atrx* in glutamatergic neurons of male and female mice. This approach bypasses the deleterious effects of the ATRX loss of function that we previously observed during brain development caused by replication stress in proliferating neuroprogenitors ([@bib21]; [@bib93]). A comprehensive analysis of these mice reveals that ATRX loss impairs long-term spatial learning and memory associated with morphological and synaptic ultrastructural changes in the hippocampus. We show that female mice lacking ATRX in neurons are protected from spatial learning and memory defects and identify sex-specific effects of ATRX loss on the expression of synaptic transcripts and miR-137. Overall, we identify a sex-specific function for ATRX in neurons in the regulation of long-term spatial memory associated with abnormal synapse ultrastructure.

Results {#sec2}
=======

Generation of Atrx-cKO^Male^ Mice {#sec2.1}
---------------------------------

We generated mice lacking ATRX in postnatal forebrain excitatory neurons using Cre/loxP-mediated recombination of the *Atrx* gene with the *CaMKII-*Cre driver line of mice ([@bib85]). Immunofluorescence staining of control (Ctrl^Male^) and knockout (*Atrx*-cKO^Male^) brain cryosections obtained from 3-month-old male mice confirms the loss of ATRX protein in the cortex and hippocampus ([Figures 1](#fig1){ref-type="fig"}A and 1B). Co-staining for ATRX and the neuronal marker NeuN shows that ATRX is highly expressed in the hippocampal neurons of the CA1, CA2/3, and dentate gyrus, but is absent in these cells in *Atrx*-cKO^Male^ mice ([Figure 1](#fig1){ref-type="fig"}C). Western blot analysis demonstrates that ATRX protein is reduced by \~80% in the rostral and caudal cortices and the hippocampus ([Figure 1](#fig1){ref-type="fig"}D). qRT-PCR shows that *Atrx* transcript levels are decreased by 78% (±9.4%) and 81% (±1.7%) in the cortex and hippocampus, respectively ([Figure 1](#fig1){ref-type="fig"}E). *Atrx*-cKO^Male^ mice survive to adulthood but exhibit reduced body weight ([Figure 1](#fig1){ref-type="fig"}F).Figure 1Neuronal Inactivation of *Atrx* in Atrx-cKO^Male^ Mice Causes Altered Hippocampal Morphology(A and B) Immunofluorescence of the cortex (A) and hippocampus (B) of Ctrl^Male^ and Atrx-cKO^Male^ mice. Scale bar: 100 μm for cortex, 200 μm for hippocampus.(C) Co-staining of ATRX (red) and NeuN (green) shows absence of ATRX in hippocampal neurons in Atrx-cKO^Male^ mice. CA1: cornu ammonis 1, CA2: cornu ammonis 2, CA3: cornu ammonis 3, DG: dentate gyrus. Scale bar: 200 μm.(D) Western blot of ATRX in rostral cortex (RC), caudal cortex (CC), hippocampus (Hip), and cerebellum (Ceb) of Ctrl^Male^ and Atrx-cKO^Male^ mice. The fold change in protein expression normalized to INCENP (loading control) is indicated below.(E) *Atrx* RNA transcripts were measured by qRT-PCR in the rostral cortex (Ctx) (p \< 0.005) and hippocampus (Hip) (p \< 0.001) (n = 4 of each genotype).(F) Body weight of Ctrl^Male^ and Atrx-cKO^Male^ mice at 3 months of age (n = 10 each genotype; p \< 0.05 by unpaired Student's t test). MRI of 16 Ctrl^Male^ and 13 *Atrx*-cKO^Male^ fixed mouse brains.(G) Absolute total volume of Ctrl^Male^ and *Atrx*-cKO^Male^ mouse brains (p \< 0.0001).(H) Coronal views of Ctrl^Male^ and *Atrx*-cKO^Male^ brains show changes in the density of absolute volume.(I) Cumulative 3-dimensional (3D) image generated from Ctrl^Male^ and *Atrx*-cKO^Male^ mouse brains reveals altered hippocampal volume relative to brain size. Hippocampus is yellow, areas of increased volume in *Atrx*-cKO^Male^ are orange, and areas of decreased volume are green.(J) Relative volume of CA1 stratum radiatum and lacunosum moleculare between Ctrl^Male^ and *Atrx*-cKO^Male^ mice (p \< 0.05). MRI image at right shows cumulative changes in *Atrx*-cKO^Male^ compared to Ctrl^Male^ mice.(K) Relative size of CA3 pyramidal layer between Ctrl^Male^ and *Atrx*-cKO^Male^ mice (p \< 0.005). MRI image at right shows cumulative changes in *Atrx*-cKO^Male^ mice compared to controls.(L) Relative volumes of all hippocampal structures, including mean and standard deviation of Ctrl^Male^ and *Atrx*-cKO^Male^, percentage difference (%Diff), effect size, p value, and false discovery rate (FDR). Asterisks indicate p \< 0.05.See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Magnetic Resonance Imaging (MRI) Analysis Identifies Anatomical Abnormalities in the Hippocampus of Atrx-cKO^Male^ Mice {#sec2.2}
-----------------------------------------------------------------------------------------------------------------------

A T2-weighted MRI sequence from 16 Ctrl^Male^ and 13 *Atrx*-cKO^Male^ mice shows that the overall volume of the *Atrx*-cKO^Male^ brain is significantly smaller compared to controls (92.8% of control volume, p \< 0.0001; [Figure 1](#fig1){ref-type="fig"}G) and cumulative serial slices ([Figure 1](#fig1){ref-type="fig"}H) correlated with smaller body size. We thus examined hippocampal neuroanatomy relative to total brain volume ([Figure 1](#fig1){ref-type="fig"}I). The relative volumes of the CA1 stratum radiatum (SR) and the stratum lacunosum moleculare (SLM) were significantly increased in *Atrx*-cKO^Male^ mice compared to controls ([Figure 1](#fig1){ref-type="fig"}J), whereas the CA3 pyramidal layer volume was significantly decreased ([Figure 1](#fig1){ref-type="fig"}K). Relative volumes of all hippocampal regions are tabulated in [Figure 1](#fig1){ref-type="fig"}L.

We postulated that the increase in the relative volume of the CA1 SR and SLM may be due to increased length or branching of CA1 apical dendrites. To investigate this possibility, we used Golgi staining to sporadically label neurons ([Figure S1](#mmc1){ref-type="supplementary-material"}A), and Sholl analysis was performed using confocal microscopy images to evaluate apical dendrite branching of CA1 hippocampal neurons. Dendritic branching and length were not significantly different between Ctrl^Male^ and *Atrx*-cKO^Male^ CA1 neurons ([Figures S1](#mmc1){ref-type="supplementary-material"}B--S1G). Quantification of astrocytes (GFAP^+^) and microglia (IBA1^+^) and total number of cells (inferred from DAPI+ staining) identified no difference between *Atrx*-cKO^Male^ and control hippocampi ([Figures S1](#mmc1){ref-type="supplementary-material"}H--S1J). Overall, the increased relative volume of the CA1 SR and SLM cannot be explained by increased length or complexity of dendritic trees or by an increased number of cells.

Pre- and Postsynaptic Ultrastructural Defects in the CA1 Apical Dendritic Region of cKO^Male^ Mice {#sec2.3}
--------------------------------------------------------------------------------------------------

Based on the hippocampal alterations detected by MRI, we wanted to see whether we could detect ultrastructural changes in the CA1 SR-SLM area. Images of synapses were obtained by transmission electron microscopy (TEM) and various measurements performed ([Figure 2](#fig2){ref-type="fig"} A). The spatial distribution of vesicles in relation to the cleft was not significantly different between *Atrx*-cKO^Male^ and Ctrl^Male^ synapses ([Figure 2](#fig2){ref-type="fig"}B). However, the total number of vesicles, the density of the vesicles, and the number of docked vesicles was significantly decreased at *Atrx*-cKO^Male^ synapses ([Figures 2](#fig2){ref-type="fig"}C--2E). We also found that the size of the postsynaptic density (PSD) and the width of the synaptic cleft were both significantly increased ([Figures 2](#fig2){ref-type="fig"}F and 2G), whereas the length of the active zone, cluster size, or diameter of the vesicles did not vary significantly ([Figures 2](#fig2){ref-type="fig"}H--2J). These results reveal that ATRX is required for the structural integrity of the pre- and postsynapse, including maintenance of the synaptic vesicle pool at presynaptic termini and potential defects in postsynaptic protein clustering.Figure 2Ultrastructural Analysis of Atrx-cKO^Male^ CA1 Apical Synapses(A) Representative images of Ctrl^Male^ and Atrx-cKO^Male^ CA1 synapses imaged by transmission electron microscopy. Red indicates presynaptic bouton, and the postsynaptic spine is blue. Scale bar, 200 nm.(B) Number of vesicles in 50-nm bins from the active zone (p = 0.95).(C) Number of total vesicles (p \< 0.01).(D) Density of vesicles per cluster (p \< 0001).(E) Number of docked vesicles (p \< 0.05).(F) Area of the postsynaptic density (PSD) (p \< 0.005).(G) Synaptic cleft width (p \< 0.0001).(H) Length of the presynaptic active zone (p = 0.70).(I) Synaptic vesicle cluster size (p = 0.99).(J) Vesicle diameter (p = 0.19).All of the data in (B)--(J) were obtained from 104 Ctrl^Male^ synapses and 84 Atrx-cKO^Male^ synapses from 3 brains of each genotype. The data were analyzed by unpaired Student's t test (C--J) or 2-way repeated-measures ANOVA with Sidak's multiple comparisons test (B). The data are displayed as means ± SEMs in (B)--(J).

Atrx Deletion in Excitatory Neurons Causes Spatial Learning and Memory Deficits {#sec2.4}
-------------------------------------------------------------------------------

We then performed behavior tests on Ctrl^Male^ and *Atrx*-cKO^Male^ mice. Locomotor activity in the open field test was not significantly different between the two genotypes, either over time (F = 0.17, p = 0.68) or when considering total distance traveled (T = 0.67, p = 0.51; [Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B). The *Atrx*-cKO^Male^ mice did not spend more time in the center of the chamber over time (F = 2.96, p = 0.09; [Figure S2](#mmc1){ref-type="supplementary-material"}C). However, they spent significantly more total time in the center of the chamber compared to controls (T = 2.26, p = 0.03; [Figure S2](#mmc1){ref-type="supplementary-material"}D), indicating that the loss of ATRX in neurons has an anxiolytic effect. This result was confirmed by the behavior of the *Atrx*-cKO^Male^ mice in the elevated plus maze, where they spent significantly more time in the open arm of the maze compared to controls (T = 2.16, p = 0.04; [Figure S2](#mmc1){ref-type="supplementary-material"}E). We observed no difference in percentage of alternation in the Y maze (T = 0.94, p = 0.35; [Figure S2](#mmc1){ref-type="supplementary-material"}F), nor in the training phase of the novel object recognition task (Ctrl^Male^ T = 1.13, p = 0.27; *Atrx*-cKO^Male^ T = 1.66, p = 0.11; [Figure S2](#mmc1){ref-type="supplementary-material"}G) or memory tests at 1.5 h (Ctrl^Male^ T = 4.28, p \< 0.001; *Atrx*-cKO^Male^ T = 3.55, p \< 0.005) or 24 h (Ctrl^Male^T = 1.65, p = 0.11; *Atrx*-cKO^Male^ T = 2.46, p \< 0.05) following training ([Figure S2](#mmc1){ref-type="supplementary-material"}H).

To investigate the effects of ATRX ablation on spatial learning and memory, we tested the mice in the Morris water maze task. The *Atrx*-cKO^Male^ mice exhibited a significant increase in latency to find the platform on day 3 of the learning portion of the task compared to controls; however, by day 4, they were able to find the platform as quickly as control mice (F = 4.62, p = 0.04; [Figure 3](#fig3){ref-type="fig"} A). This finding was reflected in the distance traveled to find the platform (F = 4.83, p = 0.04; [Figure 3](#fig3){ref-type="fig"}B). Swim speed was comparable to controls over the 4 days of learning the task (F = 0.04, p = 0.84; [Figure 3](#fig3){ref-type="fig"}C). Memory was tested on day 5 (24 h after the last training day) and day 12 (7 days after the last training day). On day 5, both Ctrl^Male^ mice (F = 29.36, p \< 0.0001) and the *Atrx*-cKO^Male^ mice (F = 18.97, p \< 0.0001) spent significantly more time in the target quadrant than the left, opposite, or right quadrants, signifying intact spatial memory ([Figure 3](#fig3){ref-type="fig"}D). However, on day 12, the *Atrx*-cKO^Male^ mice did not spend significantly more time in the target quadrant (F = 1.42, p = 0.26), whereas controls mice did (F = 6.79, p \< 0.01), suggesting a long-term spatial memory deficit ([Figure 3](#fig3){ref-type="fig"}E). *Atrx*-cKO^Male^ mice froze significantly less in the contextual fear memory task in comparison to their control counterparts 24 h after a foot shock (over time F = 5.39, p = 0.03; total time T = 2.32; p = 0.03; [Figures 3](#fig3){ref-type="fig"}F and 3G). From these results, we conclude that neuronal ATRX is required in male mice for long-term hippocampal-dependent spatial memory.Figure 3Sexually Dimorphic Impairment of Long-Term Spatial Memory upon Loss of Neuronal ATRX(A) Latency to reach the platform in the Morris water maze (p \< 0.05).(B and C) Distance traveled (p \< 0.05) (B), and swimming speed (p = 0.84) (C) over 4 days of training (4 trials/day) in the Morris water maze task (n = 15 each genotype).(D and E) Time spent in each quadrant after removal of the platform on day 5 (D) and (E) on day 12 (E). The dotted lines indicate chance at 25% and asterisks indicate significant difference to the target (T) quadrant (n = 15 each genotype).(F) Time freezing over 360 s during the contextual fear conditioning task (p \< 0.05) (n = 22 each genotype).(G) Total time freezing (p \< 0.05) (n = 22 each genotype).(H--J) Latency to reach the platform in the Morris water maze (p = 0.07) (H), distance traveled (p = 0.25) (I), and swimming speed (p = 0.28) (J) over 4 days of training (4 trials/day) in the Morris water maze (Ctrl^Fem^ n = 15, Atrx-cKO^Fem^ n = 12).(K and L) Time spent in each quadrant after removal of the platform on probe day 5 (K) and on probe day 12 (L). The dotted line indicates chance at 25%.and asterisks indicate significant difference to the target (T) quadrant (p \< 0.05).(M) Time freezing (p = 0.88).(N) Total time freezing during the contextual fear conditioning task (p = 0.88).Statistics by two-way repeated-measures ANOVA with Sidak's multiple comparisons test was applied in (A)--(C), (F), (H)--(J) and (M). One-way ANOVA was applied in (D) and (E), (K), and (L). Student's t test was used for (G) and (N). See also [Figures S2--S5](#mmc1){ref-type="supplementary-material"}.

Neuron-Specific Deletion of Atrx in Female Mice Does Not Cause Memory Deficits {#sec2.5}
------------------------------------------------------------------------------

To determine whether the loss of ATRX in female mice would cause similar behavioral defects, we generated *Atrx*-cKO female mice (*Atrx*-cKO^Fem^) by mating *Atrx* ^*f/f*^ female mice to *Atrx* ^f/Y^;*CamKIICre* ^*+/−*^ male mice. The *Atrx*-cKO^Fem^ progeny from this cross survived to adulthood, had a normal appearance, and did not display any overt behavioral defects. We verified *Atrx* deletion by immunofluorescence staining and qRT-PCR ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3C). In the open field test, *Atrx*-cKO^Fem^ mice exhibit the same level of locomotion over time (F = 1.24, p = 0.28) and travel the same distance as the Ctrl^Fem^ mice (T = 1.11, p = 0.28; [Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). Likewise, *Atrx*-cKO^Fem^ mice did not spend more time in the center during the open field test compared to control mice (over time F = 0.01, p = 0.93; total time T = 0.10, p = 0.93; [Figures S4](#mmc1){ref-type="supplementary-material"}C and S4D), In the elevated plus maze, the *Atrx*-cKO^Fem^ mice spent a similar amount of time in the exposed open arm as control mice (T = 0.49, p = 0.63; [Figure S4](#mmc1){ref-type="supplementary-material"}E), indicating that the decreased anxiety levels are specific to *Atrx*-cKO^Male^ mice.

*Atrx*-cKO^Fem^ had normal latency to reach the platform during the Morris water maze training sessions and traveled the same distance and at the same speed as Ctrl^Fem^ mice (latency F = 3.63, p = 0.07; distance F = 1.39, p = 0.25; speed F = 1.24, p = 0.28; [Figures 3](#fig3){ref-type="fig"}H--3J). Memory of the platform location remained equivalent to that of controls when tested on probe day 5 or probe day 12 (Ctrl^Fem^ day 5 F = 12.80, p \< 0.0001; *Atrx*-cKO^Male^ day 5 F = 11.63, p \< 0.001; Ctrl^Fem^ day 12 F = 16.47, p \< 0.0001; *Atrx*-cKO^Fem^ day 12 F = 12.97, p \< 0.0001; [Figures 3](#fig3){ref-type="fig"}K and 3L). Finally, there was no difference in freezing behavior between Ctrl^Fem^ and *Atrx*-cKO^Fem^ 24 h after foot shock in the contextual fear-conditioning task (over time F = 0.02, p = 0.88; total time T = 0.15, p = 0.88; [Figures 3](#fig3){ref-type="fig"}M and 3N).

We also compared the data obtained in female and male mice to determine whether there are sex or genotype effects. There is no effect of genotype, but a significant effect of sex in total distance traveled (p = 0.0001) and time spent in the center (p \< 0.0001) during the open field test, as female mice traveled a shorter distance and spent less time in the center than male mice ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B). A Sidak post hoc multi-comparison test identifies significantly increased time spent in the center area for the *Atrx*-cKO^Male^ mice. Analysis of the time spent in the target quadrant during the day 12 probe test of the Morris water maze finds no effect of sex or genotype (2-way ANOVA, p = 0.08; [Figure S5](#mmc1){ref-type="supplementary-material"}C). In the fear conditioning test, we identified a sex effect but not a genotype effect (2-way ANOVA, p = 0.0002 and p = 0.09, respectively) in which female mice spent less time freezing at the 24 hour time point compared to male mice. Applying a post hoc multi-comparison test shows that *Atrx*-cKO^Male^ mice spent significantly more time freezing than did same sex controls ([Figure S5](#mmc1){ref-type="supplementary-material"}D). We conclude from these results that male mice behave differently from female mice regardless of genotype in the open field test and in the fear conditioning task and that ATRX loss in forebrain excitatory neurons does not affect learning and memory in female mice, at least in the tests performed here.

Impaired Object Location Associative Memory in the Rodent Version of the Paired-Associate Learning (dPAL) Task {#sec2.6}
--------------------------------------------------------------------------------------------------------------

Given the male-specific defects in spatial memory, we performed additional cognitive tasks on the *Atrx*-cKO^Male^ and Ctrl^Male^ mice. The dPAL touchscreen task in mice is analogous to cognitive testing done in humans by the Cambridge Neuropsychological Test Automated Battery (CANTAB) ([@bib58]; [@bib68]), and normal performance on this task is thought to depend in part on the hippocampus ([@bib14]; [@bib39]).

Ctrl^Male^ and *Atrx*-cKO^Male^ mice were trained to identify the position of three images as depicted in [Figure 4](#fig4){ref-type="fig"} A by undergoing 36 trials per day for 10 weeks. The results demonstrate that the *Atrx*-cKO^Male^ mice exhibit a profound deficit in this task, indicated by both the percentage of correct nose pokes (F = 10.53, p \< 0.01; [Figure 4](#fig4){ref-type="fig"}B) and the number of correction trials required (F = 30.64, p \< 0.0001; [Figure 4](#fig4){ref-type="fig"}C; [Videos S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc3){ref-type="supplementary-material"}). These defects could not be attributed to an inability to perform within the chamber or to attentional deficits, as latencies to a correct answer (F = 0.48, p = 0.49), to an incorrect answer (F = 0.13, p = 0.73), and to retrieve the reward (F = 0.98, p = 0.33) were not significantly different between Ctrl^Male^ and *Atrx*-cKO^Male^ mice ([Figures 4](#fig4){ref-type="fig"}D--4F). To determine whether the impairment in the dPAL task is caused by a vision problem rather than a learning defect, the mice were also tested in the visual paired discrimination (VPD) automated touchscreen task in which the mice must discriminate between two images regardless of their position on the screen. While the *Atrx*-cKO^Male^ mice took significantly longer to reach the criterion pretesting (T = 2.95, p \< 0.01; [Figure 4](#fig4){ref-type="fig"}G), there was no difference in the percentage of correct nose pokes during the baseline tests or after reversal compared to control mice, indicating that vision is intact in the *Atrx*-cKO^Male^ mice (F = 1.39, p = 0.25; [Figure 4](#fig4){ref-type="fig"}H). They did, however, require an increased number of correction trials, suggesting that their cognitive flexibility may be marginally impaired compared to controls (F = 11.84, p = 0.002; [Figure 4](#fig4){ref-type="fig"}I). The results of these tests reinforce the notion that *Atrx*-cKO^Male^ mice have significant deficits in learning and memory.Figure 4Atrx-cKO^Male^ Mice Display Deficits in the Paired-Associate Operant Task(A) Representative images used in the paired-associate learning task, in which touching the (+) stimuli on the screen results in reward and the (−) stimuli results in negative reinforcement ([@bib80]).(B) Percentage correct over 10 weeks (p \< 0.005). Dotted line indicates percentage correct by chance.(C) Number of correction trials required over 10 weeks (p \< 0.0001).(D) Latency to choose a correct answer (p = 0.49).(E) Latency to choose an incorrect answer (p = 0.72).(F) Latency to retrieve the reward (p = 0.33).(G) Number of days to reach criterion in the visual paired discrimination (VPD) task (p \< 0.01).(H) Percentage correct during baseline (2 days) and reversal (10 days) (p = 0.25).(I) Number of correction trials required during baseline and reversal trials (p \< 0.005).For the PAL task, n = 13 Ctrl^Male^ and n = 16 Atrx-cKO^Male^ mice. For the VPD task, n = 14 Ctrl^Male^ and n = 15 Atrx-cKO^Male^ mice. Statistics by 2-way repeated-measures ANOVA with Sidak's multiple comparisons test were applied in all of the panels, except for (G), in which Student's t test was applied. Asterisks indicate p \< 0.05. See also [Videos S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc3){ref-type="supplementary-material"}.

Video S1. Ctrl^Male^ Performance during the Paired-Associate Operant Task, Related to Figure 4

Video S2. Atrx-cKO^Male^ Performance during the Paired-Associate Operant Task, Related to Figure 4

Transcriptional Changes Caused by Deletion of Atrx in Hippocampal Neurons {#sec2.7}
-------------------------------------------------------------------------

To identify the molecular mechanisms leading to spatial memory impairment, we performed RNA sequencing of hippocampi obtained from three pairs of Ctrl^Male^/*Atrx-*cKO^Male^ and Ctrl^Fem^/*Atrx*-cKO^Fem^ mice. Principal-component analysis of detected transcripts (n = 126,928 transcripts) confirms the difference between male and female mice ([Figure S6](#mmc1){ref-type="supplementary-material"}A). We analyzed the effects of ATRX loss for each sex independently (DESeq2, false discovery rate \[FDR\] \< 0.1), yielding 1,024 differentially expressed transcripts in Atrx-cKO^Male^ versus Ctrl^Male^ mice and 2,463 differential transcripts between Atrx-cKO^Fem^ and Ctrl^Fem^ mice ([Figure 5](#fig5){ref-type="fig"} A; [Tables S1](#mmc4){ref-type="supplementary-material"} and [S2](#mmc5){ref-type="supplementary-material"}). Among the 491 transcripts downregulated in *Atrx-*cKO^Male^ mice, 42 were also downregulated in *Atrx*-cKO^Fem^ mice ([Figure S6](#mmc1){ref-type="supplementary-material"}B). Among the 533 transcripts upregulated in *Atrx-*cKO^Male^ mice, 7 were also significantly upregulated in *Atrx*-cKO^Fem^ mice ([Figure S6](#mmc1){ref-type="supplementary-material"}B**)**. We also identified 25 transcripts significantly associated with the loss of ATRX in both sexes, but with opposite directionality. Predictably, many transcripts are differentially expressed according to sex ([Figure S6](#mmc1){ref-type="supplementary-material"}B). Among the 10,476 transcripts associated with sex in both KO and control mice, 5,157 were upregulated and 5,224 were downregulated in male compared with female mice, respectively ([Figure S6](#mmc1){ref-type="supplementary-material"}B).Figure 5Identification of Hippocampal Transcripts Differentially Expressed According to Sex and Genotype(A) RNA sequencing analysis was performed on Ctrl^Male^(C-M), Atrx-cKO^Male^(K-M), Ctrl^Fem^(C-F), and Atrx-cKO^Fem^(K-F) hippocampi (n = 3 each genotype), and an expression heatmap of the transcripts altered upon loss of ATRX was generated in male (left) and in female (right) mice, respectively (FDR \< 0.1).(B) Functional classification of sexually dimorphic transcripts identified in the hippocampus (biological processes, FDR \< 0.05).(C) List of genes included in the top category "synapse organization" identified by pathway analysis.(D) Transcripts differentially expressed as a function of sex and genotype clustered into 4 categories. The number of genes in each cluster is indicated at right.(E) Summary heatmaps of transcripts in clusters 1--4 identified in (D).See also [Figure S6](#mmc1){ref-type="supplementary-material"} and [Tables S1](#mmc4){ref-type="supplementary-material"}, [S2](#mmc5){ref-type="supplementary-material"}, and [S3](#mmc6){ref-type="supplementary-material"}.

We identified 1,054 transcripts differentially expressed with genotype as a function of sex (sex^∗^genotype interaction, FDR \< 0.05) ([Table S3](#mmc6){ref-type="supplementary-material"}). Functional classification revealed that these transcripts are enriched in biological processes such as "synapse organization," "cell projection organization," and "neurogenesis" ([Figure 5](#fig5){ref-type="fig"}B). We list the 41 transcripts corresponding to the top category \"synpase organization\" GO: 0050808; ([Figure 5](#fig5){ref-type="fig"}C), including many well-known synaptic molecules such as SH3 and multiple ankyrin repeat domains protein 2 (Shank2). Thus, comparative transcript profiling of the hippocampus identifies many synaptic transcripts that are altered as a function of sex and genotype, implicating them in either causing deficits in the Atrx-cKO^Male^ mice or perhaps protecting Atrx-cKO^Fem^ mice but not Atrx-cKO^Male^ from such deficits.

The transcripts exhibiting sex^∗^genotype interaction were further categorized into 4 clusters with similar patterns of expression across samples ([Figure 5](#fig5){ref-type="fig"}D). There are 292 transcripts that are upregulated in Atrx-cKO^Fem^ versus Ctrl^Fem^ but downregulated in Atrx-cKO^Male^ versus Ctrl^Male^ hippocampus (cluster 1), 134 transcripts upregulated in Atrx-cKO^Male^ versus Ctrl^Male^ but largely unchanged in Atrx-cKO^Fem^ versus Ctrl^Fem^ (cluster 2), 262 transcripts downregulated in Atrx-cKO^Fem^ versus Ctrl^Fem^ but upregulated in Atrx-cKO^Male^ versus Ctrl^Male^ hippocampus (cluster 3), and 366 transcripts that are downregulated in Atrx-cKO^Fem^ versus Ctrl^Fem^ but not altered in Atrx-cKO^Male^ versus Ctrl^Male^ (cluster 4). Heatmaps of the transcripts identified in each cluster are shown in [Figure 5](#fig5){ref-type="fig"}E and cluster annotations are listed in [Table S3](#mmc6){ref-type="supplementary-material"}.

Regulation of miR-137 and Its Target Genes by ATRX {#sec2.8}
--------------------------------------------------

Considering the presynaptic defects identified by EM and the transcriptional profiling results, we next considered the potential contribution of microRNAs (miRNAs) downstream of ATRX that may regulate synaptic pathways. Certain miRNAs are enriched within presynaptic terminals and have been implicated in neurotransmitter release by controlling the expression of SNARE and other synaptic vesicle proteins ([@bib67]). These miRNAs include miR-485, miR-34a, miR-137, and miR-27b. Using a candidate approach, we set out to directly test whether these miRNAs could be regulated by ATRX, with differential effects in male and female cKO hippocampi. qRT-PCR analysis showed similar expressions of miR-485, miR-34a, and miR-27b in male or female cKO hippocampi compared to controls. Conversely, we observed a striking and significant sex-specific effect of ATRX loss on the expression of miR-137 ([Figure 6](#fig6){ref-type="fig"} A). The latter is upregulated in the Atrx-cKO^Male^ compared to Ctrl^Male^ hippocampi but significantly reduced in Atrx-cKO^Fem^ compared to Ctrl^Fem^ ([Figure 6](#fig6){ref-type="fig"}A). We curated 3,512 genes that are predicted targets of miR-137 and investigated how corresponding transcripts are expressed across our 4 groups (Ctrl^Male^/*Atrx-*cKO^Male^ and Ctrl^Fem^/*Atrx*-cKO^Fem^). We identified 203 miR-137 targets that were differentially associated with genotype according to sex (sex^∗^genotype interaction; Lancaster p \< 0.05, from aggregated transcripts) ([@bib95]; [Table S3](#mmc6){ref-type="supplementary-material"}). GO analysis of this sub-list identified enrichment for biological processes such as "neurogenesis," "generation of neurons," and "neuron differentiation" ([Figure 6](#fig6){ref-type="fig"}B). Enrichment for cellular components identified "clathrin coat of coated pit," "presynaptic membrane," "apical plasma membrane," and "presynapse" as some of the top categories ([Figure 6](#fig6){ref-type="fig"}C), corresponding to the presynaptic defects we identified by EM. Several of the gene targets showing sex^∗^genotype interaction, such as *Shank2*, *Oxr1*, *Cse1l*, and *Myo1C* have previously been validated as miR-137 targets ([@bib13]; [@bib16]; [@bib36]; [@bib48]; [Figure 6](#fig6){ref-type="fig"}D). Other differentially expressed genes, including *Cacna1g*, *Glrb*, *Synpo*, *Huwe-1*, and *Adcyap1r1* have not yet been experimentally validated ([Figures 6](#fig6){ref-type="fig"}D and [S7](#mmc1){ref-type="supplementary-material"}). We introduced the putative miR-137 target sequence for these genes at the 3′ UTR of a luciferase reporter construct. Neuro2A cells expressing lentiviral miR-137 were transfected with the luciferase constructs, and luciferase activity was measured 48 h later. The results show a decrease in luciferase activity for each putative miR-137 target compared to vector alone, reaching statistical significance for *Cacna1g* and *Glrb* ([Figure 6](#fig6){ref-type="fig"}E). A miR-137 inhibitor significantly increased luciferase expression for *Cacna1g*, *Huwe-1,* and *Glrb* constructs. We also show that a mutated version of the *Glrb* target sequence lacked the ability to suppress luciferase activity when compared to the wild-type version ([Figure 6](#fig6){ref-type="fig"}F). The evidence suggests that miR-137 is differentially expressed upon the loss of ATRX in male and female mice, as well as some of its gene targets.Figure 6Sexually Dimorphic Effects of *Atrx* Neuronal Deletion on the Expression of miR-137 and Some of Its Target Genes(A) qRT-PCR analysis of miR-485, miR-34a, miR-485, and miR-137 in Ctrl^Male^, Atrx-cKO^Male^, Ctrl^Fem^, and Atrx-cKO^Fem^ hippocampi normalized to a control miRNA (miR-191).(B and C) Top GO enrichment categories for biological processes (B) and cellular components (C) obtained from the list of predicted miR-137 targets differentially expressed according to sex and genotype.(D) Examples of transcripts that are differentially expressed according to sex and genotype and that were previously validated (*Shank2*, *Oxr1*, *Cse1l*, *Myo1C*) or that are predicted (*Adcyap1r1*, *Glrb*) miR-137 targets.(E) Candidate miR-137 target genes were tested by a dual luciferase reporter assay with empty vector (Control) or the wild-type miR-137 gene target sequence in the presence or absence of a miR-137 inhibitor (n = 3).(F) The predicted miR-137 binding sites of the *GlrB* 3′ UTR sequence can mediate suppression of the luciferase gene, while a mutated sequence or the presence of a miR-137 inhibitor alleviates this repression (p \< 0.05, Student's t test). Sequences of the *Glrb WT* and *Glrb MUT* are shown below the graph.The data are displayed as means ± SEMs, and asterisks indicate p \< 0.05. See also [Figure S7](#mmc1){ref-type="supplementary-material"} and [Table S3](#mmc6){ref-type="supplementary-material"}.

Analysis of sequence data previously published by us and others ([@bib45]; [@bib69]) shows that the miR-137 genomic locus has four major ATRX binding sites in mouse embryonic stem cells (annotated P1--P4; [Figure 7](#fig7){ref-type="fig"} A). These sites correspond to peaks of histone H3.3 and of the suppressive histone mark H3K27me3 ([Figure 7](#fig7){ref-type="fig"}A). Loss of ATRX does not interfere with H3.3 occupancy at these sites, but there is a dramatic decrease in H3K27me3 in the ATRX KO mouse embryonic fibroblasts ([Figure 7](#fig7){ref-type="fig"}A). We generated Neuro2A ATRX KO cells (male neuroblastoma cells) using the CRISPR-Cas targeting approach ([Figure 7](#fig7){ref-type="fig"}B) and show that they exhibit a \~3.5-fold increase in miR-137 expression compared to control cells ([Figure 7](#fig7){ref-type="fig"}C); this provides an adequate model of our *in vivo* observations in the male hippocampus. We performed chromatin immunoprecipitation for ATRX, H3.3, and H3K27me3 in Neuro2A control and ATRX KO cells. qPCR of P1, P2, P3, and P4 sites show binding of ATRX at all 4 sites, similar to our observation in embryonic stem cells. H3.3 is also enriched at all sites, but it is not significantly changed in the ATRX KO cells. Conversely, H3K27me3 occupancy is significantly decreased at P1, P3, and P4 sites in ATRX null Neuro2A cells compared to controls ([Figure 7](#fig7){ref-type="fig"}D). Based on these results, we conclude that ATRX directly regulates miR-137 expression and that the observed increase of miR-137 in ATRX null cells may be caused, at least in part, by decreased trimethylation at H3 lysine 27.Figure 7ATRX Occupies the miR-137 Gene Locus and Regulates H3K27me3 Occupancy(A) Chromatin immunoprecipitation sequencing (ChIP-seq) of ATRX in embryonic stem cells (ESCs) ([@bib69]), H3.3 in control and ATRX KO newborn forebrain ([@bib45]), and H3K27me3 in mouse embryonic fibroblasts (MEFs) ([@bib69]) at the miR-137 genomic locus. Predicted G-quadruplex-forming sequences and guanine-cytosine (GC) percent are shown below the ChIP-seq tracks. P1--P4 refers to 4 major peaks of ATRX occupancy.(B) Western blot validating CRISPR-Cas9-mediated KO of ATRX in Neuro2A cells. INCENP levels were used to normalize ATRX expression.(C) Increased expression of miR-137 in ATRX KO compared to wild-type Neuro2A cells (p \< 0.05, Student's t test).(D) ChIP-qPCR of ATRX, H3.3, and H3K27me3 in Neuro2A cells shows occupancy at the P1, P2, P3, and P4 sites of the miR-137 locus, as depicted in (A). The loss of ATRX does not affect H3.3 occupancy, but it does lead to decreased H3K27me3 at the miR-137 locus (n = 3, asterisks indicate p \< 0.05, Student's t test).

Discussion {#sec3}
==========

This study presents evidence that ATRX is required in a sex-specific manner in excitatory forebrain neurons for normal spatial learning and memory. Loss of ATRX in the *Atrx*-cKO^Male^ mice resulted in various hippocampal-dependent memory impairments, including contextual fear memory, and spatial learning and memory in the Morris water maze and paired-associate touchscreen tasks. The results from the touchscreen task are especially valuable, considering their translational potential ([@bib9]), and that comparable results to humans are achieved using mouse models of cognitive impairment ([@bib57], [@bib58]).

Examination of the ATRX mutant brain by MRI identified hippocampal morphological defects that may be related to the memory impairments. We originally hypothesized that the increased volume of the CA1 SR and SLM may be due to increased branching of pyramidal neurons, particularly the apical dendrites that project to this region. However, analysis of Golgi-stained CA1 neurons failed to identify abnormalities in dendritic branching that would explain the MRI data. Astrocyte and microglia infiltration have been linked with defects in learning and memory in various mouse models ([@bib4]; [@bib52]; [@bib82]). However, after examination of these cell types by immunofluorescence staining, we detected no change in either astrocyte or microglia cell number. The reason for the volume increase thus remains undetermined, but may be caused by an increased volume of the perineuronal net (changes to the extracellular matrix), which has been shown to help regulate learning and memory ([@bib7]; [@bib33]). An alternative explanation is that volumetric measurements are normal in these areas, but decreased elsewhere in the hippocampus.

There are two hippocampal pathways implicated in spatial learning and memory, the Schaffer collateral pathway and the temporoammonic pathway. The Schaffer collateral pathway involves the CA3 axons projecting to the CA1 medial apical dendrites ([@bib89]), whereas the temporoammonic pathway initiates in layer III of the entorhinal cortex and projects to the CA1 middle apical dendritic layer ([@bib54]). We recently reported impaired hippocampal apical dendritic CA1 long-term potentiation (LTP), which could account for the spatial memory deficits reported here ([@bib29]). The temporoammonic pathway, thought to be critical for long-term spatial memory recall or consolidation ([@bib6]; [@bib65]), showed significantly reduced LTP in anesthetized Atrx-cKO^Male^ mice compared to control mice ([@bib29]).

Unexpectedly, *Atrx*-cKO^Fem^ mice did not show impairments in learning and memory paradigms. In humans, females harboring *ATRX* mutations are largely protected from the disease as a result of the skewing of X-inactivation ([@bib23]); however, this is not the case here, since the mice were homozygous for the "floxed" allele and we confirmed by immunofluorescence staining that ATRX is indeed absent from hippocampal excitatory neurons. Sexual dimorphism has been reported in other mouse models with mutations in chromatin remodeling proteins, including CHD8 and MeCP2, in which females are unaffected by the loss of the protein of interest or are affected differently ([@bib37]; [@bib40]; [@bib42]). Developmental neurological diseases such as autism spectrum disorders tend to preferentially affect males, possibly due to combinatorial contributions of hormonal and genetic factors in a phenomenon known as the female protective effect ([@bib19]; [@bib35]; [@bib90]), and this has repeatedly been demonstrated in mouse models ([@bib32]; [@bib70]; [@bib87]). The presence of estrogen and estrogen receptor in the female brain has been shown to be neuroprotective and lead to enhanced Schaffer collateral LTP ([@bib92]). In addition, certain X-linked genes involved in chromatin regulation (e.g., *Utx*, a histone demethylase) are able to escape X-inactivation and thus are expressed 2-fold in females compared to males ([@bib94]). These mechanisms could lead to protective effects in the *Atrx*-cKO^Fem^ mice, causing sexually dimorphic defects in learning and memory. We previously reported impairment of spatial learning and memory in a female mouse model with mosaic expression of ATRX in all types of cells of the central nervous system ([@bib81]). This suggests the intriguing possibility that female-specific protective factors originate from cell types other than the excitatory neurons targeted in the present study. Female-specific glial factors, for example, may provide important protection against the loss of ATRX in neurons.

Another mechanism that could explain the divergent behaviors between male and female mice is the opposite effect of ATRX loss on miR-137 expression. miRNAs are critical for the regulation of transcriptional programs in the brain. At the molecular level, miRNAs can target hundreds to thousands of genes, thereby altering the expression of proteins at the presynaptic terminal, the postsynaptic membrane, or both. The TEM and RNA sequencing data obtained in the present study identified impaired presynaptic vesicular function, with a decreased number of docked and total vesicles. miR-137 overexpression has previously been linked to impaired hippocampal-dependent learning and memory in the Morris water maze and contextual fear conditioning task, similar to the *Atrx*-cKO mice ([@bib76]). In addition, miR-137 overexpression results in altered vesicular trafficking and reduced LTP *in vivo* and a reduction in the number of docked and total vesicles *in vitro* ([@bib31]; [@bib76]), again paralleling our findings in *Atrx*-cKO^Male^ mice. miR-137 is also known to regulate the expression of genes involved in postsynaptic function, including *N*-methyl-[d]{.smallcaps}-aspartate (NMDA) and AMPA receptor synthesis ([@bib59]; [@bib97]) and multiple targets in the phosphatidylinositol 3-kinase-Akt-mammalian target of rapamycin (PI3K-Akt-mTOR) pathway ([@bib84]). Therefore, the increased expression of miR-137 could explain the presynaptic defects seen in *Atrx-*cKO male mice and may have other effects within the PSD and downstream signaling that should be examined in more detail in the future. Several sexually dimorphic miR-137 target genes were identified that may contribute to the memory deficits in males or their absence in females. SHANK2 acts as a scaffolding protein within the PSD of excitatory synapses, connecting glutamate receptors to the actin-based cytoskeleton ([@bib73]). Oxidation resistance 1 (OXR1) has been implicated in limiting oxidative stress-mediated DNA damage ([@bib60]). Very recently, *Oxr1* null mutations were identified in an autosomal-recessive neurological disorder associated with severe global developmental delay, intellectual disability, language delay, cerebellar atrophy, and seizures ([@bib36]; [@bib98]). Moreover, the inhibition of miR-137 or the upregulation of its target gene *Oxr1* ameliorated oxidative stress injury in a Parkinson disease model ([@bib36]). Glycine receptor B (*GLRB*) mutations cause congenital hyperekplexia, a neuromotor disorder characterized by stiffness and easily provoked startle responses, and many cases also have developmental cognitive delay ([@bib83]). The HECT, UBA, and WWE domain containing 1 (*HUWE1*) gene encodes a E3 ubiquitin ligase that targets its substrates for proteasomal degradation via poly-ubiquitination. *HUWE1* mutations are associated with intellectual disability ([@bib53]). A *HUWE1* mutation was identified in an affected male from the original family reported by Juberg and Marsidi that was originally erroneously attributed to an *ATRX* mutation ([@bib20]), highlighting the similarity of clinical phenotypes incurred by *ATRX* and *HUWE1* mutations. It is possible that the effects of ATRX neuronal deletion on memory derive from the misregulation of many different miR-137 targets in the hippocampus.

We determined that ATRX binds four distinct sites at the miR-137 gene locus that are also occupied by the histone variant H3.3. Although ATRX and the DAXX histone chaperone have been implicated in H3.3 deposition at some genomic sites, we observed no change in H3.3 levels at miR-137 in ATRX null Neuro2A cells, perhaps due to compensatory mechanisms. Conversely, we detected a significant decrease in the suppressive histone mark H3K27me3, offering a potential mechanism for miR-137 de-repression in ATRX null cells.

Unfortunately, the coronavirus disease 2019 pandemic limited our ability to complete a number of experiments that would have further supported our conclusions. In particular, additional analyses of *Atrx*-cKO^Fem^ mice would have helped to further strengthen the connection between the molecular findings and the sexually dimorphic phenotypes. In addition, modulation of the miR-137 levels in the hippocampus would provide more direct evidence of its association with the observed synaptic defects and memory deficits. Nevertheless, our study presents strong evidence that ATRX is required in forebrain excitatory neurons for spatial learning and long-term memory and the regulation of genes required for efficient synaptic transmission.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**anti-ATRX H-300Santa Cruz Biotechnology, Incsc-15408anti-NeuNMilliporeMAB377; RRID:[AB_2298772](nif-antibody:AB_2298772){#interref175}anti-GFAPAgilent Technologies, IncM0761; RRID:[AB_2109952](nif-antibody:AB_2109952){#interref180};anti-IBA1Wako Pure Chemical Corporation019-19741; RRID:[AB_839504](nif-antibody:AB_839504){#interref185}anti-INCENPSigmaI5283; RRID:[AB_477113](nif-antibody:AB_477113){#interref190}anti-ATRXAbcamab97508; RRID:[AB_10680289](nif-antibody:AB_10680289){#interref195}anti-H3K27me3Millipore07-449; RRID:[AB_310624](nif-antibody:AB_310624){#interref200}anti-H3.3Millipore17-10245: RRID:[AB_10953839](nif-antibody:AB_10953839){#interref205}Normal rabbit IgGCell Signaling2729S; RRID:[AB_1031062](nif-antibody:AB_1031062){#interref210}anti-Rabbit-HRPJackson ImmunoResearch Laboratories, Inc111-036-003; RRID:[AB_2337942](nif-antibody:AB_2337942){#interref215}**Bacterial and Virus Strains**pmirGLO vectorPromegaE1330PX459 plasmid (Addgene)[@bib64]62988Lenti-III-mico-GFP vector, viral titer \> 10^7^ IU/mlApplied Biological MaterialsMIMAT0000149**Chemicals, Peptides, and Recombinant Proteins**XbaINEBR0145SBbsINEBR0539SAnti-miR miRNA Inhibitor; miR-137-3pThermoFisherAM17000KpnINEBR0142S**Critical Commercial Assays**SuperScript II Reverse TranscriptaseInvitrogen18064022miRVANA total RNA isolation kitThermoFisherAM1560TaqMan Advanced MicroRNA reverse transcription kitThermoFisherA28007TaqMan Universal PCR Master Mix, no AmpEraseTaqMan Universal PCR Master Mix, no AmpEraseThermoFisher4324018Rapid GolgiStain KitFD Neurotechnologies, IncPK401RNA 6000 Nano kitCaliper Life Sciences5067-1511ScriptSeq Complete Gold Kit (H/M/R)Illumina Inc.BHMR1205**Deposited Data**RNA sequencing of hippocampi from control and Atrx-cKO males and femalesThis studyGEO: [GSE129975](ncbi-geo:GSE129975){#intref0015}**Experimental Models: Cell Lines**Neuro2AATCCCCL-131**Experimental Models: Organisms/Strains**Mouse: CaMKII-Cre: B6.Cg-Tg(Camk2a-cre)T29-1Stl/JJackson Laboratory005359Mouse: Atrx^fl/fl^Gift from Doug Higgs and Richard GibbonsN/A**Oligonucleotides**Oligonucleotides for qRT-PCR[Table S4](#mmc7){ref-type="supplementary-material"}N/AOligonucleotides for sgRNA[Table S4](#mmc7){ref-type="supplementary-material"}N/AOligonucleotides for ChIP-PCR[Table S4](#mmc7){ref-type="supplementary-material"}N/A**Software and Algorithms**Adobe Photoshop CS6AdobeRRID:[SCR_014199](rridsoftware:SCR_014199){#intref0020};Version 13.0OpenLabAgilentRRID:[SCR_012158](rridsoftware:SCR_012158){#intref0025}Volocity 3D Image Analysis SoftwarePerkinElmerRRID:[SCR_002668](rridsoftware:SCR_002668){#intref0030}; Demo Version 6.0.1mni_autoreg tools[@bib10]RRID:[SCR_013621](rridsoftware:SCR_013621){#intref0035}; <http://www.bic.mni.mcgill.ca/software/mni_autoreg/>ANTS (advanced normalization tools)[@bib1]RRID:[SCR_004757](rridsoftware:SCR_004757){#intref0045}; <http://www.picsl.upenn.edu/ANTS/>FIJI[@bib71]RRID:[SCR_002285](rridsoftware:SCR_002285){#intref0055}<https://fiji.sc>Prism 6.0GraphpadRRID:[SCR_002798](rridsoftware:SCR_002798){#intref0065}; <https://www.graphpad.com>Simple Neurite Tracer[@bib49]RRID:[SCR_016566](rridsoftware:SCR_016566){#intref0075}; <https://imagej.net/Simple_Neurite_Tracer>ANY-MazeStoelting Co.RRID:[SCR_014289](rridsoftware:SCR_014289){#intref0085}cutadapt[@bib51]RRID:[SCR_011841](rridsoftware:SCR_011841){#intref0090}; version 0.4.1HISAT2[@bib39]RRID:[SCR_015530](rridsoftware:SCR_015530){#intref0095}; version 2.0.4SAMtools[@bib47]RRID:[SCR_002105](rridsoftware:SCR_002105){#intref0100}; <http://www.htslib.org/>StringTie[@bib61]RRID:[SCR_016323](rridsoftware:SCR_016323){#intref0110}; v1.3.3; <https://ccb.jhu.edu/software/stringtie/>tximport[@bib77]RRID:[SCR_016752](rridsoftware:SCR_016752){#intref0120}; <https://bioconductor.org/packages/release/bioc/html/tximport.html>DESeq2[@bib50]RRID:[SCR_015687](rridsoftware:SCR_015687){#intref0130}; <https://bioconductor.org/packages/release/bioc/html/DESeq2.html>pheatmap[@bib41]RRID:[SCR_016418](rridsoftware:SCR_016418){#intref0140}; <https://cran.r-project.org/web/packages/pheatmap/index.html>Lancaster method[@bib95]N/A**Other**Bussey-Saksida mouse touch screen chambersLafayette NeuroscienceModel 80614-20

Resource Availability {#sec4.2}
---------------------

### Lead Contact {#sec4.2.1}

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Nathalie G. Bérubé (<nberube@uwo.ca>).

### Materials Availability {#sec4.2.2}

All plasmids generated in this study are available upon request.

### Data and Code Availability {#sec4.2.3}

The accession number for the RNA sequencing data reported in this paper can be accessed at GEO: GSE129975. Data analysis and graphical representations were performed using R scripts and publicly available packages as denoted in the methods detail section. All scripts are available upon request.

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Mouse models {#sec4.3.1}

The *Atrx* ^*loxP*^ mice have been described previously ([@bib3]). *Atrx* ^*loxP*^ mice were mated with C57BL/6 mice expressing Cre recombinase under the control of the *αCaMKII* gene promoter ([@bib86]). The progeny includes hemizygous male mice that produce no ATRX protein in forebrain excitatory neurons (*Atrx*-cKO). The *Atrx*-cKO males were mated to *Atrx* ^*loxP*^ females to yield homozygous deletion of *Atrx* in female mice (*Atrx*-cKO^Fem^). Male and female littermate floxed mice lacking the Cre allele were used as controls (Ctrl^Fem^). Genotyping of tail biopsies for the presence of the floxed and Cre alleles was performed as described previously ([@bib3]). Mice were exposed to a 12-hour-light/12-hour-dark cycle and with water and chow *ad libitum*. Behavioral assessments were performed using male and female mice of 3 to 6 months of age, starting with less demanding tasks (open field tests, elevated plus maze) to more demanding ones (Morris water maze). ARRIVE guidelines were followed: mouse groups were randomized, experimenters were blind to the genotypes, and software-based analysis was used to score mouse performance in all the tasks. All behavioral experiments were performed between 9:00 AM and 4:00 PM. An analysis of the influence (or association) of sex on the hippocampal transcriptome and on several behaviors was performed. All procedures involving animals were conducted in accordance with the regulations of the Animals for Research Act of the province of Ontario and approved by the University of Western Ontario Animal Care and Use Committee (2017-048).

### Cell lines {#sec4.3.2}

Neuro2a (ATCC® CCL131) male neuroblastoma cells were cultured in Eagle's Minimum Essential Medium (EMEM; Life Technologies), supplemented with 10% fetal bovine serum (FBS; Life Technologies) at 37°C and 5% CO2 in a humidified incubator. The cells were confirmed to be negative for mycoplasma. Cell line authentication was not done.

Method Details {#sec4.4}
--------------

### Immunofluorescence staining {#sec4.4.1}

Mice were perfused with 25 mL phosphate buffered saline (PBS) followed by 25 mL 4% paraformaldehyde (PFA) in PBS and the brain fixed for 24 hours in 4% PFA in PBS and cryopreserved in 30% sucrose/PBS. Brains were flash frozen in Cryomatrix (Thermo Scientific) and sectioned at 8 μm thickness as described previously ([@bib93]). For immunostaining, antigen retrieval was performed by incubating slides in 10 mM sodium citrate at 95°C for 10 min. Cooled sections were washed in PBS, permeabilized in 0.3% Triton X-100 and blocked with 10% normal goat serum (Sigma) for one hour. The slides were incubated overnight in primary antibody (ATRX: 1:200, NeuN: 1:200, GFAP: 1:200, IBA1: 1:500) diluted in 0.3% Triton-X/PBS. Sections were washed in 0.3% Triton-X/PBS 3x 5 min and incubated with secondary antibody (1:800) for one hour. Sections were washed again three times for 5 min, counterstained with DAPI and mounted with SlowFade Gold (Invitrogen). All images were captured using an inverted microscope (Leica DMI 6000b) with a digital camera (Hamamatsu ORCA-ER). Openlab image software was used for manual image capture, and images were processed using the Volocity software and Adobe Photoshop CS6. Cell counts of DAPI, GFAP, and IBA1 were performed in Adobe Photoshop. DAPI was counted per mm^2^ and GFAP and IBA1 were counted as percentages of DAPI^+^ cells. One section from five pairs of Ctrl^Male^/*Atrx*-cKO^Male^ was counted. Statistical significance was determined using an unpaired Student's t test.

### Reverse transcriptase real-time PCR {#sec4.4.2}

Total RNA was isolated from control and *Atrx*-cKO frontal cortex and hippocampus using the miRVANA total RNA isolation kit (ThermoFisher) and reverse transcribed to cDNA using 1 μg RNA and SuperScript II Reverse Transcriptase (Invitrogen). Real-time PCR was performed in duplicate using gene-specific primers under the following conditions: 95°C for 10 s, 58°C for 20 s, 72°C for 30 s for 35 cycles. All data were normalized against β-actin expression levels. Total RNA was also used for reverse transcription of miRNA using the TaqMan Advanced MicroRNA reverse transcription kit (ThermoFisher). qRT-PCR was performed using the TaqMan Universal PCR Master Mix, no AmpErase (ThermoFisher) using advanced probes for miR-137-3p (mmu480924_mir), miR-34a-5p (mmu481304_mir), miR-27b-3p (mmu478270_mir), miR-485-5p (mmu482774_mir), and normalized to miR-191-5p (mmu481584_mir) under the following PCR conditions: 95°C for 10 min, 45 cycles of 95°C for 15 s and 60°C for 1 min. All primers are listed in [Table S4](#mmc7){ref-type="supplementary-material"}.

### Western blot analysis {#sec4.4.3}

Whole cell lysates were collected in standard RIPA buffer and quantified using a Bradford assay (BioRad). Protein lysates (50 μg) were loaded on a 6% SDS-PAGE gel and transferred to nitrocellulose membrane (BioRad) using a wet electroblotting system (BioRad). The membrane was blocked in 5% milk in Tris-buffered saline with 0.1% Tween-20 (SigmaAldrich) for 1 hour and incubated overnight at 4°C with primary antibody (ATRX: 1:500, INCENP: 1:3000). The following day the membrane was washed and incubated in the appropriate horseradish peroxidase-conjugated secondary antibody (1:4000). The membrane was rinsed briefly in enhanced chemiluminescence substrate (BioRad), exposed to film and quantified using ImageJ.

### Magnetic resonance imaging {#sec4.4.4}

Mice were perfused with 30 mL of PBS supplemented with 1 μL/mL heparin (Sandoz) and 2mM ProHance (Bracco Imaging Canada) followed by 30 mL 4% paraformaldehyde supplemented with 2mM ProHance. After perfusion, mice were decapitated, and the skin, cartilaginous nose tip, and lower jaw were removed. The remaining brain and skull structures were incubated in PBS supplemented with 2 mM ProHance and 0.02% sodium azide for at least one month before MRI scanning ([@bib12]). A multi-channel 7.0 Tesla MRI scanner (Agilent Inc., Palo Alto, CA) was used to image the brains within their skulls. Sixteen custom-built solenoid coils were used to image the brains in parallel ([@bib56]). In order to detect volumetric changes, we used the following parameters for the MRI scan: T2- weighted, 3-D fast spin-echo sequence, with a cylindrical acquisition of k-space, a TR of 350 ms, and TEs of 12 ms per echo for 6 echoes, field-of-view equaled to 20 × 20 × 25 mm3 and matrix size equaled to 504 × 504 × 630. Our parameters output an image with 0.04 mm isotropic voxels. The total imaging time was 14 hours ([@bib78]).

### MRI Registration and Analysis {#sec4.4.5}

To visualize and compare any changes in the mouse brains, the images are linearly (6 followed by 12 parameter) and non-linearly registered together. Registrations were performed with a combination of mni_autoreg tools ([@bib10]) and ANTS (advanced normalization tools) ([@bib1]). All scans are then resampled with the appropriate transform and averaged to create a population atlas representing the average anatomy of the study sample. The result of the registration is to have all images deformed into alignment with each other in an unbiased fashion. For the volume measurements, this allows for the analysis of the deformations needed to take each individual mouse's anatomy into this final atlas space, the goal being to model how the deformation fields relate to genotype ([@bib44]; [@bib55]). The jacobian determinants of the deformation fields are then calculated as measures of volume at each voxel. Significant volume differences can then be calculated by warping a pre-existing classified MRI atlas onto the population atlas, which allows for the volume of 182 different segmented structures encompassing cortical lobes, large white matter structures (i.e., corpus callosum), ventricles, cerebellum, brain stem, and olfactory bulbs ([@bib15]; [@bib63]; [@bib66]; [@bib79]; [@bib88]) to be assessed in all brains. Further, these measurements can be examined on a voxel-wise basis to localize the differences found within regions or across the brain. Multiple comparisons in this study were controlled for using the False Discovery Rate ([@bib22]).

### Golgi staining and analysis {#sec4.4.6}

Brains from 3-month-old mice were stained using the FD Rapid GolgiStain Kit (FD Neurotechnologies, Inc). They were then flash frozen and sectioned on a cryostat at 100 μm thickness and further processed as per kit instructions. Hippocampal CA1 pyramidal neurons were imaged on a laser scanning confocal microscope (Leica SP5). *z*-Stacks were obtained of whole neurons (10-15 *z-*intervals per neuron). 65 Ctrl and 51 *Atrx*-cKO neurons were traced from 3 Ctrl/*Atrx*-cKO pairs. Dendrites were analyzed in ImageJ (FIJI) using the Simple Neurite Tracer plugin; the traces were analyzed using the Sholl plugin in ImageJ (FIJI) at a radius step size of 4 μm ([@bib18]; [@bib49]). Statistics were calculated by two-way repeated-measures ANOVA with Sidak's multiple comparison test or unpaired Student's t tests where applicable.

### Transmission electron microscopy {#sec4.4.7}

Mice were perfused with 4% paraformaldehyde (VWR) dissolved in phosphate buffer and sectioned at 500 μm on a Vibratome Series 1000 Sectioning System. Sections were post-fixed overnight in 4% paraformaldehyde for 24h and in 1% glutaraldehyde for 1 hour, then washed and left in phosphate buffer until preparation of ultra-thin sections. Slices were transferred to the Biotron facility at Western University for the remaining steps. Coronal slices from the hippocampal layer were rinsed in distilled water, post-fixed for one hour at room temperature in 1% osmium tetroxide (Electron Microscopy Sciences Warrington, PA) and 1.5% potassium ferrocyanide and post-fixed for a second hour in 1% osmium tetroxide ([@bib30]). The slices were quickly dehydrated through a graded series of ethanol, rinsed in 100% acetone and then infiltrated with inversion for one hour in 50% epon-araldite resin and placed overnight in 100% resin on a rotator. The slices were polymerized overnight at 60°C in a vented oven, sandwiched between two sheets of Aclar film covered with a light weight ([@bib5]). The hippocampal region was cut from the resin-embedded slice using a razor blade and mounted on a blank epoxy block using cyanoacrylate glue. Semi-thin sections were made with a Reichert Ultracut ultramicrotome and stained with toluidine blue and used to select the CA1 neuropil region for ultrathin sectioning. Thin sections (100 nm) were collected on 200 mesh nickel grids (EMS), post-stained with lead citrate and images were collected with a Philips 420 transmission electron microscope equipped with an AMT 4K megapixel XR41S-B camera (Woburn, MA). Images were captured within the stratum radiatum / stratum lacunosum moleculare at 9200X in a semi-random manner to obtain at least 50 synapses containing a distinct synaptic cleft without regard to the length of the cleft. Image analysis was performed in ImageJ. A total of 104 Ctrl^Male^ and 84 *Atrx-*cKO^Male^ synapses were quantified from 3 Ctrl^Male^ and 3 *Atrx*-cKO^Male^ mice. Synapses were binned in 50 nm increments from the active zone and the number of docked vesicles and vesicles in each bin were counted; this also determined total number of vesicles per synapse. Vesicle cluster size was measured to calculate vesicle density. The area of the post-synaptic density was also quantified. Statistics were calculated by two-way repeated-measures ANOVA with Sidak's multiple comparison test or unpaired Student's t tests where applicable.

### Open field test {#sec4.4.8}

In the open field test, locomotor activity was automatically recorded (AccuScan Instrument). The mice were placed in an arena with an area of 20 cm x 20 cm with 30 cm high walls. Mice were acclimated to the room for ten minutes prior to testing. Locomotor activity was measured in 5 min intervals over 2 hours as previously described ([@bib81]). Distance traveled and time spent in the center were recorded. Statistics were calculated by two-way repeated-measures ANOVA with Sidak's multiple comparison test or unpaired Student's t tests where applicable.

### Elevated plus maze {#sec4.4.9}

Animals were placed in the center of the elevated plus maze (Med Associate Inc) and their activity was recorded over 5 min. Total time spent in the open and closed arms was recorded using computer software (AnyMaze). The center of the mouse body was used as an indicator of which zone they were in. Statistics were calculated by unpaired Student's t tests.

### Y maze test {#sec4.4.10}

Animals were placed in the center of a symmetrical three-armed Y maze as described ([@bib11]; [@bib81]). Each mouse underwent one trial of 5 minutes. Order of arm entry was recorded using computer software (AnyMaze) and spontaneous alternation was counted when a mouse entered all three arms in a row without visiting a previous arm.

### Novel object recognition task {#sec4.4.11}

Mice were habituated in an open arena with no objects for 5 minutes on Day 1 and Day 2, as described ([@bib81]). On Day 3, mice were exposed to two identical objects for ten minutes (A; a red plastic ball attached on top of a yellow cube base). Video tracking (AnyMaze) was used to record time spent with each object. To test short-term memory, mice were exposed to the original object (A) and a novel object (B; a blue plastic pyramid attached on top of a green prism base) 1.5 hours after training. To test long-term memory, mice were exposed to (A) and (B) 24 hours after training. Novel object recognition was expressed as the percentage of time spent with the novel object as a fraction of the total time spent interacting. Interaction was defined as sniffing or touching the object, but not leaning against or climbing on the object.

### Morris water maze {#sec4.4.12}

The Morris water maze was conducted as described previously ([@bib91]). The task was performed in a 1.5 m diameter pool with 25°C water and the platform was submerged 1 cm beneath the water surface. Spatial cues (shapes printed in black & white) were distributed around the pool. Mice were given four trials (90 s) a day for 4 consecutive days with a 15 min intertrial period. The latency, distance, and swim speed to find the platform was recorded using video tracking software (AnyMaze). If the mice did not find the platform within 90 s, they were gently guided onto the platform. On the fifth and the twelfth days the platform was removed, and time spent in each quadrant of the maze was recorded using the video software. Statistics were calculated by one- or two-way repeated-measures ANOVA with Sidak's multiple comparison test, where applicable.

### Contextual fear conditioning {#sec4.4.13}

To measure contextual fear memory, mice were placed in a 20 cm x 10 cm clear acrylic enclosure with a metal grid floor and one wall distinct from the others (stripes were drawn on one of the walls). The chamber was equipped with an electric shock generator. Videos were recorded using the AnyMaze video tracking software. On Day 1, mice could explore the enclosure freely and at 150 s the mice were given a shock (2 mA, 180 V, 2 s). After 30 s, the mice were returned to their home cage. The next day (24 h), the mice were placed back into the enclosure for 6 min and freezing time was measured in 30 s intervals. Freezing was defined as immobility lasting more than 0.5 s. Statistics were calculated by two-way repeated-measures ANOVA with Sidak's multiple comparison test or unpaired Student's t tests where applicable.

### Touchscreen assays {#sec4.4.14}

The paired associate learning (dPAL) and visual paired discrimination (VPD) and reversal tasks were performed as previously described ([@bib8]; [@bib14]; [@bib80]). Animals were food-restricted to 85% starting body weight. Animals were separated into two counter-balanced subgroups to control for time of day of testing, and equipment variation. Mice were tested in Bussey-Saksida mouse touch screen chambers (Lafayette Neuroscience) with strawberry milkshake given as a reward. For the dPAL acquisition phase, animals were tested for their ability to associate objects with locations. Mice were presented with two images in two of three windows; one image was in its correct location (S+) and one was in one of its two incorrect locations (S-). The third window was blank. A correct response triggered reward presentation and start of an inter-trial period. The pre-training was repeated until mice reached criterion (completion of 36 trials within 60 minutes). The dPAL evaluation phase was performed for 45 sessions over 9 weeks. A correct response triggered reward presentation, whereas an incorrect response caused a 5 s time out and the house lights to turn on. An incorrect response also resulted in a correction trial, where the same S+/S- images were presented in the same two locations until the mouse responded correctly. The mouse was given 36 trials over 60 minutes per day. Percent correct, number of correction trials, latency to a correct or incorrect response, and latency to retrieve reward were recorded for each week.

VPD acquisition required the animal to touch the same image (S+) no matter which window it appeared in. The other screen had an incorrect image (S-). A correct response triggered reward presentation, whereas an incorrect response triggered the house lights to turn on, a time out of 5 s, and a correction trial to begin (previous trial repeated until a correct choice is made). This was repeated until mice reached criterion of 24/30 trials correct within 60 minutes over 2 consecutive days, after which baseline measurements were done for two sessions. Parameters for baseline were identical to the acquisition steps. Immediately following baseline measurements, the VPD task reversal began, where most parameters were the same as the acquisition, but the correct image associated with the reward was S-, and the incorrect response that triggers house lights was S+. The mouse was given 30 trials per day over 10 days. Percent correct, number of correction trials needed, latency to a correct or incorrect response, and latency to retrieve reward on each day were recorded. Statistics were calculated by two-way repeated-measures ANOVA with Sidak's multiple comparison test or unpaired Student's t tests where applicable.

### RNA sequencing {#sec4.4.15}

Hippocampal total RNA was isolated using the miRVANA RNA isolation kit (ThermoFisher) from three pairs of 3-month-old Ctrl^Male^, AtrxcKO^Male^, Ctrl^Fem^ and AtrxcKO^Fem^ mice (12 samples total). RNA was quantified using the Qubit 2.0 Fluorometer (Thermo Fisher Scientific, Waltham, MA) and quality was assessed using the Agilent 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA) with the RNA 6000 Nano kit (Caliper Life Sciences, Mountain View, CA). Libraries were prepared, including rRNA reduction, using the ScriptSeq Complete Gold Kit (H/M/R) (Illumina Inc., San Diego, CA). Samples were fragmented, cDNA was synthesized, tagged, cleaned-up and subjected to PCR with barcoded reverse primers (ScriptSeq Index PCR Primers) to permit equimolar pooling of samples into one library. The pooled library size distribution was assessed with an Agilent High Sensitivity DNA Bioanalyzer chip and quantitated using the Qubit 2.0 Fluorometer. All samples were sequenced at the London Regional Genomics Centre (Robarts Research Institute, London, Ontario, Canada; <http://www.lrgc.ca>) using the Illumina NextSeq 500 (Illumina Inc., San Diego, CA). The libraries were sequenced as a paired end run, 2 x76 bp, using a High Output v2 kit (150 cycles). Fastq data files were downloaded from BaseSpace. At least 60 million fragments were obtained for each sample. Raw reads were pre-processed with the sequence-grooming tool cutadapt ([@bib96]) version 0.4.1 with the following quality trimming and filtering parameters (\`--phred33--length36 -q 5--stringency 1 -e 0.1\`). Each set of paired-end reads was mapped against the *Mus musculus* GRCm38.p6 primary assembly downloaded from Ensembl ([@bib61]) release 94 (<https://useast.ensembl.org/Mus_musculus/Info/Annotation>) using HISAT2 version 2.0.4. SAMtools was then used to sort and convert SAM files. The read alignments and *Mus musculus* GRCm38 genome annotation were provided as input into StringTie v1.3.3 ([@bib77]) which returned gene and transcript abundances for each sample. We imported coverage and abundances for transcripts into R using the tximport ([@bib50]) R package and conducted differential analysis of transcript count data stratified or not on sex using the DESeq2 R package. We use the independent hypothesis weighting (IHW) Bioconductor package ([@bib34]) to weight p values and adjust for multiple testing using the procedure of Benjamini Hochberg (BH) ([@bib2]). We first identified transcripts associated with ATRX loss in male and female independently (ie stratified analysis). For the unstratified analysis, an interaction term was added to the model to test if the effect of *Atrx* deletion differs according to sex. K-means clustering based on Euclidean distance was used to cluster significant transcripts in four groups. Clustering and heatmap visualization were conducted using the pheatmap R package. To further investigate the association between ATRX loss and expression of miR137 targets, we curated the literature to list 3,512 genes and tested association of the expression of the corresponding transcripts with the sex^∗^genotype interaction term as described above using DESeq2 R/Bioconductor package. Transcripts p values were then aggregated using the Lancaster method ([@bib95]).

### Generation of ATRX knockout cell line by CRISPR Cas9 {#sec4.4.16}

Two single-guide RNA (sgRNA1 and sgRNA2) sequences targeting two loci in exon 9 of the mouse *Atrx* gene were designed by using the CRISPR design tool (<https://www.benchling.com/crispr/>). Pairs of DNA oligonucleotides harboring sgRNA1 and sgRNA2 sequences ([Table S4](#mmc7){ref-type="supplementary-material"}) were individually annealed and ligated into the BbsI (NEB) site of the PX459 plasmid (Addgene \#62988) as previously described by [@bib64]). After gRNA1 and gRNA2 cloning into PX459 plasmid, a dual-guide RNA (gRNA1+gRNA2) cassette was assembled on the gRNA1-containing PX459 plasmid. Briefly, the gRNA2-containing cassette (U6 promoter-gRNA2-gRNA scaffold) was amplified and inserted into XbaI (NEB) and KpnI (NEB) sites of gRNA1-containing PX459 plasmid. Neuro2A cells were transfected with dual-guide RNA containing PX459 plasmid by Lipofectamine 3000 (ThermoFisher), according to the manufacturer's instructions. Transfected cells were selected with Puromycin (2μg/ml) for 3-5 days and then diluted to obtain the individual clones.

### Chromatin immunoprecipitation {#sec4.4.17}

Neuro2A and Neuro2A-ATRXKO cells were grown in DMEM for 48 hours, collected in 10mL DMEM and crosslinked in 1% formaldehyde. The cells were lysed in SDS buffer and sonicated. Immunoprecipitation was performed with the following antibodies: anti-ATRX (Abcam, ab97508), anti-H3K27me3 (Millipore, 07-449), anti-H3.3 (Millipore, CS207327). Rabbit IgG (Cell Signaling) was used as a control. Input samples represent 1/25 of total chromatin input. Real-time PCR experiments were conducted as follows: 95°C for 5 min, 40 cycles of 95°C for 10 s, 60°C for 20 s, and 72°C for 30 s. This procedure was repeated in triplicate. Primers used to amplify the P1-P4 regions are listed in [Table S4](#mmc7){ref-type="supplementary-material"}.

### Dual-luciferase reporter assay {#sec4.4.18}

Several reporter plasmids were constructed containing the putative target sequence for miR-137 identified in the *Cacna1g*, *Glrb*, *Synpo*, *Huwe-1* and *Adcyap1r1* 3′UTR. For *Glrb*, we also constructed a reporter plasmid with a mutant form of the target site. Neuro2A cells were infected with a lenti-GFP mmu-miR-137-3p miRNA virus (Lenti-III-mico-GFP vector, viral titer \> 10^7^ IU/ml, miRNA ID: MIMAT0000149; Applied Biological Materials; abm, Vancouver, Canada) 48 hours before transfection with the reporter plasmids in the presence or absence of 80nM miR-137 inhibitor (Anti-miR miRNA Inhibitor, Thermofisher Scientific). The cells were collected and lysed 48 hours later and luciferase activity was detected using a Dual-LuciferaseR Reporter Assay System kit (E1910, Promega Corporation, Madison, WI, USA). The ratio of firefly luciferase to renilla luciferase was regarded as relative luciferase activity.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Data collection and analyses were performed blind to the conditions of the experiment. Sample sizes were not pre-determined and similar to those reported in the literature. For MRI and behavior experiments, 'n' refers to number of separate mice. All data were analyzed using GraphPad Prism software with Student's t test (unpaired, two-tailed) or one-way ANOVA for experiments with one variable or two-way repeated-measures ANOVA with post hoc test for experiments with two variables. All results are depicted as mean ± SEM unless indicated otherwise. P values of less than 0.05 were considered to indicate significance. All statistical details are outlined in the [Method Details](#sec4.4){ref-type="sec"} section and in the figure legends.
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